Brightsurf Science News and Current Science News Events
 

Chemotherapeutic Agent News | Chemotherapeutic Agent Current Events
Page 1 of 14 | 338 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
Chemotherapy causes delayed severe neural damage
Cancer treatment with chemotherapeutic agents is often associated with delayed adverse neurological consequences - an occurrence often referred to as "chemobrain" - that may compromise the quality of life of a proportion of cancer survivors.   view more (2008-04-22)

Why cisplatin kills breast cancer cells when other drugs fail
The cancerous cells of some individuals with breast cancer lack expression of two cell surface proteins, the estrogen and progesterone receptors, and do not express increased amounts of HER2.   view more (2007-04-20)

Cell skeleton may hold key to overcoming drug resistance in cancer
Researchers have uncovered a new way in which a cell protein protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients.   view more (2007-10-04)

Enzyme may hold key to improved targeting of cancer-fighting drugs
A critical enzyme used to prepare a powerful cancer-killing agent may be able to help drug makers better target the cells the natural product attacks, according to findings published in the May 23 edition of the Journal of Biological Chemistry.   view more (2008-05-30)

Genes identified that protect against heart damage from chemotherapy
A series of genes that protect cells from the powerful, common chemotherapeutic agent doxorubicin has been identified by researchers working to understand how the drug also can destroy the heart.   view more (2007-12-04)

Researchers Discover New Method to Treat Cancer
Research at Oxford University's Institute of Molecular Medicine has identified a novel therapeutic regimen for the treatment of cancer that provides significant advantages over the existing methods of cancer treatment. There are already a number of regimens available for treatment of cancer,... view more (2003-03-20)

International Study Suggests Carboplatin Could Be First-line Chemotherapy Drug For Ovarian Cancer
Results of an international study in this week's issue of THE LANCET suggest that the drug carboplatin could become a first-line chemotherapeutic agent for the treatment of ovarian cancer. Carboplatin was found to be less toxic, although it had no overall survival benefit, compared with other drugs... view more (2002-08-14)

Synergistic growth inhibitory effect of herbal extracts against HCC and lung cancer cells
Several herbs with diversified pharmacological properties are known to be rich sources of chemical constituents that may have potential for the treatment of several human cancers. Data from the Department of Preclinical Science, Faculty of Medicine, Thammasat University, demonstrates that the... view more (2008-04-30)

A 'butler' in your mobile phone: University of Southampton scientists create a computer agent that aims to make life less complicated
A new computer agent that will work through users' mobile phones and organise their business and social schedules, has been developed by scientists at the Department of Electronics and Computer Science (ECS) at the University of Southampton. The agent is an example of how the next generation of... view more (2003-06-13)

Genetic Testing For Cell-Proliferation Enzyme Could Improve Treatment Of Acute Lymphoblastic Leukaemia (p 1033)
Authors of a Canadian research letter in this week's issue of THE LANCET describe how genetic testing for an enzyme involved in cancer-cell proliferation could identify patients at an increased risk of poor outcome from acute lymphoblastic leukaemia. The enzyme thymidylate synthase is associated... view more (2002-03-20)

Tumor cells evade death through autophagy
Autophagy is a cellular process that enables cells to turnover their contents, something that they do frequently. Autophagy is initiated in tumor cells by chemotherapy and radiation, but it is not known if this contributes to tumor cell death or helps tumor cells survive the anti-cancer therapy.   view more (2007-01-19)

A Different Antiviral For Treating SARS (p 2045)
A preliminary study published as a fast-track research letter in this week's issue of THE LANCET suggests that the antiviral agent glycyrrhizin could be more effective than other antivirals in the treatment of severe acute respiratory syndrome (SARS). Ribavirin is the most commonly used antiviral... view more (2003-06-11)

Deakin University has developed a prototype tasty snack food with special health benefits
Dr Russell Keast, a senior lecturer in the school of exercise and nutrition sciences, has developed a new snack food with a parmesan cheese cracker, organic mashed potato and special healthy additives.   view more (2006-06-27)

Combined Chemotherapy and Radiotherapy for Cervical Cancer Could Increase Survival (p 781)
A systematic review of randomised trials in the past two decades published in this week’s issue of THE LANCET concludes that women given concurrent chemotherapy and radiotherapy for cervical cancer could have an increased survival-rate of 12% compared with patients treated with radiotherapy... view more (2001-09-05)

EU funding helping to find ocean remedies for cancer
European Union funding is helping to find cancer treatments for certain deadly tumours using small marine animals. European researchers are using chemical agents extracted from a type of Caribbean sea squirt, named Ecteinascidia turbinata, to treat some tumours. The breakthrough findings will soon... view more (2004-06-11)

Interesting lead in the treatment of Ewing`s sarcoma
Research scientists at INSERM, CNRS and the Institut Curie, in collaboration with physicians, have used a mouse model to demonstrate the efficacy of an innovative therapeutic approach to Ewing`s sarcoma: the combination of human interferon (alpha or beta) and a common anti-tumor agent, ifosfamide.... view more (2002-10-31)

Cancer drug extends cognitive function in patients with brain metastases
he drug Xcytrin®, based on a molecule developed by chemists at The University of Texas at Austin, shows significant promise in prolonging cognitive function in patients with non-small cell lung cancer that has metastasized to the brain.   view more (2006-06-06)

NEW DIAGNOSTIC METHOD COULD IMPROVE DETECTION OF PROSTATE CANCER (p 1849)
A new diagnostic technique using colour Doppler with an ultrasound contrast agent is more effective than conventional systematic biopsy in diagnosing prostate cancer, conclude the authors of a research letter in this week's issue of THE LANCET. Prostate cancer detection is currently based on three... view more (2001-06-06)

Exposure to Agent Orange linked to prostate cancer in Vietnam veterans
UC Davis Cancer Center physicians today released results of research showing that Vietnam War veterans exposed to Agent Orange have greatly increased risks of prostate cancer and even greater risks of getting the most aggressive form of the disease as compared to those who were not exposed.   view more (2008-08-05)

Chemotherapy can be more toxic to brain cells than to cancer cells and may cause brain damage
Drugs used to treat cancer may damage normal, healthy brain cells more than the cancer cells they are meant to target.   view more (2006-11-30)

Veterans exposed to Agent Orange have higher rates of prostate cancer recurrence
Veterans exposed to Agent Orange have a 48 percent increased risk of prostate cancer recurrence following surgery than their unexposed peers, and when the disease comes back, it seems more aggressive, researchers say.   view more (2007-05-21)

Mouse study: New muscle-building agent beats all previous ones
The Johns Hopkins scientists who first created "mighty mice" have developed, with pharmaceutical company Wyeth and the biotechnology firm MetaMorphix, an agent that's more effective at increasing muscle mass in mice than a related potential treatment for muscular dystrophy now in clinical... view more (2005-12-09)

Shaping the future of map generalisation in Europe
The future of automated map generalisation is looking bright following a workshop in the UK involving some of Europe’s major mapping agencies. Delegates from Germany, Spain, Belgium, France, Denmark, the Netherlands and the UK gathered at Laser-Scan’s headquarters in Cambridge to... view more (2002-05-22)

Scientists one step closer to cancer vaccine
Scientists at Karolinska Institutet in Sweden have helped to identify a molecule that can be used as a vaccination agent against growing cancer tumours.   view more (2006-03-22)

Cell cultures can sort out Creutzfeldt-Jacob Disease (CJD) and scrapie infectious agents
Research in Japan and at Yale University School of Medicine shows that infection with a weak strain of Creutzfeldt-Jacob Disease (CJD) prevents infection by more virulent strains and that the protection requires persistent replication by the infectious agent, but not misfolded prions.   view more (2005-10-21)
Page 1 of 14 | 338 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com